Research Links

By Malcolm Ritter, Nov 20, 2007 (Associated Press)- Scientists have made ordinary human skin cells take on the chameleon-like powers of embryonic stem cells, a startling breakthrough that might someday deliver the medical payoffs of embryo cloning without the controversy.

Laboratory teams on two continents report success in a pair of landmark papers released Tuesday. It's a neck-and-neck finish to a race that made headlines five months ago, when scientists announced that the feat had been accomplished in mice...

Nov. 13, 2007 (medindia.com)- A new study has identified key elements that may make the regeneration of nerve cells using the body's own stem cells following spinal cord injury a possibility.

The seminal study, co-lead by Dr. Philip Horner, neuroscientist at the University of Washington, Dr. Tim Kennedy, neuroscientist at the Montreal Neurological Institute of McGill University, might help in providing novel therapies for repairing previously irreversible nerve damage in the injured spinal cord...

By Patricia Khashayar MD, Nov 12, 2007 (Press TV)- Dr Sean Hu, the chairman and founder of Beike Biotechnology, got a PhD in molecular biology from Gothenburg University in Sweden; He has received his post doctoral training at the University of British Colombia in Vancouver.

Since 1999, he has decided to get involved in the business side of the research industry as well...

By Jon C. Ogg, Nov. 7, 2007 (247wallst.com)- Geron Corp. (NASDAQ:GERN) is trading up in pre-market activity on news that would have been much more eagerly received back in the emergence of stem cell news.  Geron announced that data shows its human embryonic stem cell based therapeutic candidate for spinal cord injury GRNOPC1 survives and exhibits durable and robust human remyelination in spinal cord-injured rats.  The duration was for at least nine months following a single injection...

Nov. 9, 2007 (ScienceDaily)- Neuroscientists have significantly advanced brain-machine interface (BMI) technology to the point where severely handicapped people who cannot contract even one leg or arm muscle now can independently compose and send e-mails and operate a TV in their homes. They are using only their thoughts to execute these actions...

Nov. 9, 2007 (ScienceDaily.com)- New experimental therapies are being -- or soon may be -- tested in clinical trials that could open the doors to a "golden era" for research to improve the treatments of people with spinal cord injuries, brain injuries, stroke, and other severe movement disorders, scientists say...

Nov. 7, 2007 (ScienceDaily)- Recent discoveries in the field of neuroimmunology, which studies the interaction between the immune and nervous systems, are offering promising new leads for the treatment of many devastating neurological disorders, from Alzheimer's disease to stroke.

New research suggests that reducing the expression of an immune system protein in the brain may help repair neurons damaged by spinal cord injury and other trauma...

Nov. 2, 2007 (PRNewswire)- The Neurotechnology Industry Organization (NIO) today announced the top ten emerging areas of neuroscience that will impact the future of treatments for brain and nervous system. According to NIO, the trade association that represents the 500 companies worldwide developing treatments for the brain and nervous system, the U.S. economic burden of brain-related disorders has reached more than $1 trillion, highlighting the acute need for continued neuroscience research and therapeutic development...

By Lydia Kulbida, Dec. 3, 2007 (wynt.com)- The business of working with tiny particles is going through a huge growth spurt. Nanotechnology is already used in hundreds of products, maybe even the skin cream you just put on, but how far can the technology go? And why are some predicting hazards along the way?

From cars, to condoms, to tennis balls, nanotechnology is out of the lab and in the items we use every day...